Cargando…

Blood Endothelial-Cell Extracellular Vesicles as Potential Biomarkers for the Selection of Plasma in COVID-19 Convalescent Plasma Therapy

Despite the advancement of vaccination and therapies currently available, deaths due to the coronavirus disease 2019 (COVID-19) are still heavily documented. Severely infected individuals experience a generalized inflammatory storm, caused by massive secretion of pro-inflammatory cytokines that can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amri, Nada, Tessier, Nolwenn, Bégin, Rémi, Vachon, Laurent, Bégin, Philippe, Bazin, Renée, Loubaki, Lionel, Martel, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563445/ https://www.ncbi.nlm.nih.gov/pubmed/36231083 http://dx.doi.org/10.3390/cells11193122

Ejemplares similares

Use of Early Donated COVID-19 Convalescent Plasma Is Optimal to Preserve the Integrity of Lymphatic Endothelial Cells
por: Amri, Nada, et al.
Publicado: (2022)

Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset
por: Perreault, Josée, et al.
Publicado: (2020)

The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice
por: Ullah, Irfan, et al.
Publicado: (2022)

Focus on the Lymphatic Route to Optimize Drug Delivery in Cardiovascular Medicine
por: Tessier, Nolwenn, et al.
Publicado: (2021)

Lipid metabolism of plasma-derived small extracellular vesicles in COVID-19 convalescent patients
por: Xiao, Wenjing, et al.
Publicado: (2023)

Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
por: Bégin, Philippe, et al.
Publicado: (2021)

Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
por: Beaudoin-Bussières, Guillaume, et al.
Publicado: (2020)

Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
por: Bégin, Philippe, et al.
Publicado: (2022)

Earlier the better: convalescent plasma
por: Tobian, Aaron A.R., et al.
Publicado: (2020)

The resurgence of convalescent plasma therapy
por: The Lancet Haematology
Publicado: (2020)

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

Tetraspanins distinguish separate extracellular vesicle subpopulations in human serum and plasma – Contributions of platelet extracellular vesicles in plasma samples
por: Karimi, Nasibeh, et al.
Publicado: (2022)

Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
por: Anand, Sai Priya, et al.
Publicado: (2021)

Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2
por: Gasser, Romain, et al.
Publicado: (2021)

Convalescent plasma trial shows no benefit
por: Brown, Matthew
Publicado: (2020)

Convalescent plasma to treat COVID-19
por: Bloch, Evan M.
Publicado: (2020)

Convalescent plasma for patients with COVID-19
por: Zeng, Furong, et al.
Publicado: (2020)

Convalescent plasma for COVID-19 considerations
por: Adiwinata Pawitan, Jeanne
Publicado: (2021)

Serosurveys and convalescent plasma in COVID-19
por: Pérez-Cameo, Cristina, et al.
Publicado: (2020)

COVID-19 convalescent plasma transfusion
por: Langhi, Dante Mário, et al.
Publicado: (2020)

Convalescent plasma in outpatients with COVID-19
por: Focosi, Daniele, et al.
Publicado: (2022)

Convalescent plasma: Alternative or promising therapy?
por: Mina, Fahmida Begum, et al.
Publicado: (2021)

Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial
por: Bégin, Philippe, et al.
Publicado: (2021)

Editorial: Highlights in Lipids in Cardiovascular Disease: 2021
por: Boucheniata, Chaymae, et al.
Publicado: (2022)

Profiling Extracellular Long RNA Transcriptome in Human Plasma and Extracellular Vesicles for Biomarker Discovery
por: Rodosthenous, Rodosthenis S., et al.
Publicado: (2020)

Cryo-electron microscopy of extracellular vesicles in fresh plasma
por: Yuana, Yuana, et al.
Publicado: (2013)

Glycan Node Analysis of Plasma-Derived Extracellular Vesicles
por: Walker, Sierra A., et al.
Publicado: (2020)

Plasma exchange followed by convalescent plasma transfusion in COVID-19 patients
por: Roshandel, Elham, et al.
Publicado: (2021)

Ubiquitous convalescent plasma: An artificial universal plasma for COVID-19 patients
por: Sattarzadeh Bardsiri, Mahla, et al.
Publicado: (2021)

Convalescent Plasma Therapy for Coronavirus Disease 2019
por: Choi, Jun Yong
Publicado: (2020)

The true historical origin of convalescent plasma therapy
por: Marson, Piero, et al.
Publicado: (2020)

Efficacy of convalescent plasma for the treatment of severe influenza
por: Xu, Zhiheng, et al.
Publicado: (2020)

Convalescent plasma therapy in patients with COVID-19
por: Altuntas, Fevzi, et al.
Publicado: (2021)

Convalescent plasma therapy in patients with COVID-19
por: Altuntas, Fevzi, et al.
Publicado: (2021)

Donating convalescent plasma for COVID-19 patients
por: Black, Emily
Publicado: (2020)

Challenges of Convalescent Plasma Therapy on COVID-19
por: Zhao, Qian, et al.
Publicado: (2020)

Convalescent Plasma for the Treatment of Severe COVID-19
por: Franchini, Massimo, et al.
Publicado: (2021)

Functional Antibodies in COVID-19 Convalescent Plasma
por: Herman, Jonathan D., et al.
Publicado: (2021)

Convalescent plasma in the management of COVID-19 pneumonia
por: Elbadawi, Ayman, et al.
Publicado: (2021)

How Safe Is COVID-19 Convalescent Plasma?
por: Franchini, Massimo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d53bqqga30glgimer2t8cgovju